BDX News
Becton, Dickinson and Company
$188.89
+$1.52(+0.81%)
71
Overall
95
Value
63
Tech
57
Quality
Market Cap
$51.45B
Volume
1.65M
52W Range
$140.11 - $213.08
Target Price
$189.73
BDX news: the latest Becton, Dickinson and Company headlines, press releases and market updates, newest first.
Latest BDX News
- Abingdon Health PLC Earnings Call Signals H2-Driven GrowthTipRanks Auto-Generated Newsdesk · Oct 15, 2026
- BCAL Diagnostics Evolves Into National Early Cancer Detection PlatformTipRanks Australian Auto-Generated Newsdesk · Oct 5, 2026
- RBC Capital Remains a Hold on Becton Dickinson (BDX)TipRanks Auto-Generated Intelligence Newsdesk · Oct 3, 2026
- BDX’s PureWick ICU Trial: A Quiet Catalyst for Hospital Device GrowthTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 2, 2026
- BCAL rolls out Avantect multi-cancer blood test across AustraliaTipRanks Australian Auto-Generated Newsdesk · Sep 23, 2026
- BCAL Diagnostics Sets October AGM, Streamlines Digital Shareholder ParticipationTipRanks Australian Auto-Generated Newsdesk · Sep 17, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BDX | $188.89 | +0.8% | 1.65M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Becton, Dickinson and Company Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW